Kestra Medical (KMTS) GC Traci Umberger Sells 3,580 Shares
$KMTS · KESTRA MEDICAL TECHNOLOGIES, LTD.Research Summary
AI-generated summary of this SEC filing
Kestra Medical (KMTS) GC Traci Umberger Sells 3,580 Shares
What Happened Traci S. Umberger, listed as General Counsel and Chief Administrative Officer (also noted as a director), sold 3,580 shares of Kestra Medical Technologies, Ltd. (KMTS) on August 4, 2026. The weighted-average sale price was $24.04, for total proceeds of about $86,073. The filing indicates this was a nondiscretionary sell-to-cover transaction to satisfy tax withholding obligations tied to the vesting and settlement of restricted stock units (RSUs), so this is a routine tax-related sale rather than an open-market investment decision.
Key Details
- Transaction date: 2026-08-04; Form 4 filed: 2026-08-06 (timely filing).
- Shares sold: 3,580 at a weighted-average price of $24.04; total ≈ $86,073.
- Price range reported: $23.80 to $24.42; the weighted average is shown in the filing (per footnote).
- Reason: Sell-to-cover to satisfy tax withholding on RSU vesting (footnote F1).
- Shares owned after transaction: not disclosed in the provided filing.
- Remarks: Reporting person is General Counsel & Chief Administrative Officer (also noted as director).
- The filer offers to provide the number of shares sold at each price within the reported range upon request (footnote F2).
Context Sell-to-cover transactions are common when RSUs vest; shares are sold specifically to cover tax obligations and generally do not signal a change in the insider’s view of the company. For retail investors, ongoing purchases by insiders can be a stronger bullish indicator than routine sales like tax-withholding transactions.